YORVIPATH Ambassador Program | YORVIPATH® (palopegteriparatide) Patient Site
Patient Support

Your Story Matters

The YORVIPATH Ambassador Program is an impactful way to share your chronic hypoparathyroidism journey

We’re dedicated to building a community of Ambassadors—people like you who offer authentic insights into living with chronic hypoparathyroidism.

Who you can help:

  • Patients, especially those just starting on or considering YORVIPATH
  • Medical professionals seeking more insights on the patient perspective
  • The chronic hypoparathyroidism community, which benefits from increased understanding of the disease and treatment options

How you can help: Become a YORVIPATH Ambassador so you can share your unique journey of living with chronic hypoparathyroidism.

In their own words: What the YORVIPATH Ambassador Program means to current Ambassadors

“Being a Patient Ambassador has reminded me how healing it can be to simply feel seen and heard. There’s a quiet power in telling your truth. By sharing my story with honesty and heart, I hope others feel safe to share theirs — and feel inspired and empowered to keep going. Our stories can light the way for others — to healing, to hope, and to connection.”

–Joanna

“My purpose for being an Ambassador stems from wanting to help others truly learn about hypoparathyroidism. To encourage other patients to educate themselves about how hypoparathyroidism affects their bodies physically and emotionally. I believe in equipping people with the knowledge to live a better life.”

–Lynette

Learn more

How does the YORVIPATH Ambassador Program work?

Step 1: Please complete the form below. If you fit the qualifications, a representative from our marketing communications agency, FINN Partners, will be in touch within 5 to 10 business days.

Step 2: You’ll receive an email thanking you for your interest and prompting you to schedule an initial phone call with a representative from FINN Partners. In this initial phone call, you’ll be asked to discuss your experience living with chronic hypoparathyroidism and treatment with YORVIPATH.

Step 3: If you are selected as an Ambassador, we will reach out about onboarding, training, and other potential opportunities to share your story with different audiences.

Not all registrants will be selected for the YORVIPATH Ambassador Program. If not selected, there may be an opportunity to participate in the future.

Frequently Asked Questions

IMPORTANT SAFETY INFORMATION AND USE

What is the most important information I should know about YORVIPATH®?

YORVIPATH may cause serious side effects, including:

  • High levels of calcium in the blood (hypercalcemia). YORVIPATH can cause some people to have higher blood calcium levels than normal. Your healthcare provider should check your blood calcium before you start and during your treatment with YORVIPATH. Tell your healthcare provider right away if you have nausea, vomiting...

IMPORTANT SAFETY INFORMATION AND USE

What is YORVIPATH® used for?

YORVIPATH is a prescription medicine used to treat adults with low parathyroid hormone (PTH) (hypoparathyroidism).

  • It is not known if YORVIPATH is safe and effective in people who have been recently diagnosed with hypoparathyroidism after surgery, or if it is started in people with low levels of calcium in the blood.
  • It is not known if YORVIPATH is safe and effective in children.
  • YORVIPATH should not be used in children and young adults whose bones are still growing.

What is the most important information I should know about YORVIPATH?

YORVIPATH may cause serious side effects, including:

  • High levels of calcium in the blood (hypercalcemia). YORVIPATH can cause some people to have higher blood calcium levels than normal. Your healthcare provider should check your blood calcium before you start and during your treatment with YORVIPATH. Tell your healthcare provider right away if you have nausea, vomiting, dizziness, feeling thirsty, confusion, muscle weakness, or irregular heartbeat. Hypercalcemia is more likely to occur within the first 3 months of starting YORVIPATH, but it may occur at any time.
  • Low levels of calcium in the blood (hypocalcemia). People who stop using, miss, or change a dose of YORVIPATH may have an increased risk of low blood calcium levels, but hypocalcemia may occur at any time. Tell your healthcare provider right away if you have tingling in your fingertips, toes, lips or tongue, muscle spasms or cramps, oral numbness, depression, have problems thinking or remembering, abnormal heart rhythms, or seizures.
  • Possible bone cancer (osteosarcoma). Tell your healthcare provider right away if you have pain in any areas of your body that does not go away or any new or unusual lumps or swelling under your skin that is tender to touch. These are some of the signs and symptoms of osteosarcoma and your healthcare provider may need to do further tests.

Who should not take YORVIPATH?

Do not use YORVIPATH if you are allergic to palopegteriparatide or any of the other ingredients in YORVIPATH.

What should I tell my healthcare provider before taking YORVIPATH?

Before using YORVIPATH, tell your healthcare provider about all of your medical conditions, including if you:

  • are at higher risk of a type of bone cancer called osteosarcoma. This is especially important:
    • if you have a bone disease that increases your risk of developing osteosarcoma (including if you have Paget’s disease).
    • if a blood test shows that you have unexplained increases in bone alkaline phosphatase.
    • if you have cancer of the bones or other cancer that has spread to your bones.
    • if you are having or have had radiation therapy to the skeleton.
    • if you are affected with a condition that runs in your family that can increase your chance of getting cancer in your bones.
  • take medicines that contain digoxin, are used to treat osteoporosis, or can affect calcium levels in your blood.
  • are pregnant or plan to become pregnant. It is not known if YORVIPATH will harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with YORVIPATH.
  • are breastfeeding or plan to breastfeed. It is not known if YORVIPATH passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with YORVIPATH.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. YORVIPATH and other medicines may affect each other causing side effects.

What are the possible side effects of YORVIPATH?

YORVIPATH may cause serious side effects:

  • Allergic (hypersensitivity) reaction, including anaphylaxis. Stop taking YORVIPATH and tell your healthcare provider or get emergency medical help right away if you have swelling of your face, lips, mouth, or tongue, breathing problems, fainting, dizziness, feeling lightheaded (low blood pressure), fast heartbeat, itching, rash, or hives.
  • Decrease in blood pressure when you change positions (orthostatic hypotension). Some people may feel dizzy, get a fast heartbeat, or feel light-headed right after injecting YORVIPATH. For the first few doses, give your injection of YORVIPATH in a place where you can sit or lie down right away if you get these symptoms. If your symptoms get worse or do not go away, contact your healthcare provider before you continue using YORVIPATH.
  • Digoxin toxicity if you are using digoxin and YORVIPATH at the same time. Tell your healthcare provider if you experience irregular heart rhythm, heart palpitations, confusion, loss of appetite, nausea, vomiting, diarrhea, or vision problems.

The most common side effects of YORVIPATH include injection site reactions, vasodilatory signs or symptoms such as a drop in blood pressure or lightheadedness when standing up, headache, diarrhea, back pain, high calcium levels, and sore throat.

These are not all of the possible side effects of YORVIPATH. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. You may also report side effects to Ascendis Pharma at 1-844-442-7236.

Please click here for full Prescribing Information for YORVIPATH, including the Medication Guide.

Hypopara=hypoparathyroidism.

This site is for US residents only.

Please confirm you are a US resident.

Cancel

You are about to leave the Yorvipath.com website by opening a new webpage.

The site you are linking to is not controlled or endorsed by Ascendis Pharma and we are not responsible for the content presented on that site.

Thank you for visiting Yorvipath.com.

Confirm